Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England
Woods et al.
Applied Health Economics and Health Policy.
2025.
Using Large Language Models to Assist Antimicrobial Resistance Policy Development: Integrating the Environment into Health Protection Planning
Chen et al.
Environmental Science & Technology.
2025.
Addressing urgent priorities in antibiotic development: insights from WHO 2023 antibacterial clinical pipeline analyses
Donà et al.
The Lancet Microbe.
2025.
The social burden of antimicrobial resistance: what is it, how can we measure it, and why does it matter?
Keenan et al.
JAC – Antimicrobial Resistance.
2025.
Using priorities between human and livestock bacterial antimicrobial resistance (AMR) to identify data gaps in livestock AMR surveillance
Venkateswaran et al.
BMC Infectious Diseases.
2025.
Mapping socioeconomic factors driving antimicrobial resistance in humans: An umbrella review
Ljungqvist et al.
One Health.
2025.
Human and Veterinary Medicine Collaboration: Synergistic Approach to Address Antimicrobial Resistance Through the Lens of Planetary Health.
Horvat and Kovačević.
Antibiotics.
2025.
Co-Benefits of Antimicrobial Resistance Mitigation from China’s PM2.5 Air Pollution Reduction Between 2014–2020
Zhou et al.
Engineering.
2024.